The largest database of trusted experimental protocols

6 protocols using cdc42

1

Antibody Detection Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies against the following proteins were used: human ERα (Santa Cruz Biotechnology, #sc-543); HA (hybridoma clone 12CA5; kindly provided by Peter Angel, DKFZ, Germany); Rb (BD Biosciences, #554136); c-Jun (Cell Signaling Technology, #9165), phospho-c-Jun (Ser63) (Cell Signaling Technology, #9261), myc Tag (Upstate, #06-549); E1A (Calbiochem, #DP11-100UG; Santa Cruz Biotechnology, #sc-58658); RhoA (Cytoskeleton, #ARH03), Rac1 (Upstate, #05-389); Cdc42 (Thermo Scientific, #89857D), Ezrin (Cell Signaling Technology, #3145), Radixin (Cell Signaling Technology, #2636), Moesin (Cell Signaling Technology, #3150).
+ Open protocol
+ Expand
2

Stimulating CDC42 Signaling with EGF and FGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated using EGF and FGF Recombinant Human Protein in order to stimulate CDC42 signaling pathways (Thermo Scientific, Waltham, MA, USA). Briefly, the cells were seeded in a six-well plate and starved in a serum-free DMEM for 24 h before stimulation. The cells were then treated with 20 ng/mL EGF or FGF in a total volume of 2 mL per well of the growth DMEM media (supplemented with 10% FBS).
+ Open protocol
+ Expand
3

Silencing Regulatory Genes in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stealth RNAi siRNA of FoxM1 (HSS177135), HMGCR (HSS104864), RhoA (VHS40471), Rac1 (VHS40447) and Cdc42 (VHS40393) were obtained from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). 20 nM of gene specific siRNA or Stealth RNAi siRNA Negative Control (Thermo Fisher Scientific, Inc., Waltham, MA, USA) was transfected with Lipofectamine RNAiMAX Transfection Reagent (Thermo Fisher Scientific, Inc., Waltham, MA, USA) after incubating in Opti-MEM I Reduced serum medium (Thermo Fisher Scientific, Inc., Waltham, MA, USA) as previously described [52 (link)].
+ Open protocol
+ Expand
4

Western Blot Analysis of PLD2 and Cdc42

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231/-468 cells were lysed in RIPA buffer containing protease and phosphatase inhibitors (Sigma, #P8340; #P0044). After centrifugation, proteins were recovered in the supernatant. Protein concentration was determined by the Bradford protein assay (Bio-Rad, #5000006). Proteins were separated on SDS-PAGE transferred to PVDF membranes. Primary antibodies PLD2 (1:1000; Cell Signaling, #13904) and Cdc42 (1:500; Invitrogen, #PA1-092) were used. HRP-conjugated anti-rabbit IgG (1:2000: Cell Signaling, #7074) was used as a secondary antibody. Signals were revealed using the ECL substrate (Millipore, #WBKLS0100). To normalize and verify protein amounts equally, membranes were finally stained with amido black solution (0.25% amido black, 45% MeOH, 45% ddH2O, 10% glacial HOAc) and de-stained with the same solution without dye.
+ Open protocol
+ Expand
5

siRNA Knockdown in Human ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specificities of the siRNA pools were confirmed with the following independent siRNAs: RhoA, 5′-CACAGUGUUUGAGAACUAUTT-3′ and 5′-GCUAGACGUGGGAAGAAAATT-3′; Rac1, 5′-GGAACUAAACUUGAUCUUATT-3′ and 5′-CCUUUGUACGCUUUGCUCATT-3′; Cdc42, 5′-UGAGAUAACUCACCACUGUTT-3′ and 5′-AGAUCUAGUUUAGAAAACATT-3′ (Invitrogen). siGLO RNA-induced silencing complex-free control siRNA was purchased from Thermo Fisher Scientific. In total, 50 nM siRNA was transfected into huESCs using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. The cells were then incubated in K-SFM for 24 h before further experimentation.
+ Open protocol
+ Expand
6

Antibody Validation for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies from cell signaling have been indicated before [49 (link), 50 (link)]. Other antibodies included anti-SRGAP1 antibody (1:1000, sc-81939, Santa Cruz Biotechnology, Dallas, TX, USA), RhoA (#05-778), Cdc42 (#05-542), Rac1 (#05-389), N-cadherin (33-3900, Invitrogen), and Vimentin (YM3158, ImmunoWay Biotechnology Company, Plano, TX, USA). The secondary antibodies were in line with that in our earlier work [49 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!